Ontology highlight
ABSTRACT: Background
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease. Whether extracellular vesicles are effective in treating IPF and what is the optimal administrative route is not clear. Our previous studies have shown that immunity and matrix regulatory cells (IMRCs) derived from human embryonic stem cells can safely treat lung injury and fibrosis in mouse models, and its mechanism of action is related to the paracrine effect. In this study, we investigated the therapeutic effects of IMRC-derived extracellular vesicles (IMRC-EVs) on a bleomycin-induced pulmonary fibrosis mouse model and explored the optimal route of administration.Methods
To study the biodistribution of IMRC-EVs after administration via different routes, NIR labeled-IMRC-E
SUBMITTER: Yang S
PROVIDER: S-EPMC9006546 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature